AAAAAA
Results: 1-25/57
Authors:
WAAGSTEIN F
MOBINI R
ANDERSSON B
BERGH CH
FU MLX
MCNAY J
Citation: F. Waagstein et al., MOXONIDINE ATTENUATES TRANSMYOCARDIAL NOREPINEPHRINE CONCENTRATION GRADIENT AND TOTAL-BODY NOREPINEPHRINE SPILLOVER IN CONGESTIVE-HEART-FAILURE, Circulation, 98(17), 1998, pp. 4091-4091
Authors:
ELIASSON T
MANNHEIMER C
WAAGSTEIN F
ANDERSSON B
BERGH CH
AUGUSTINSSON LE
HEDNER T
LARSON G
Citation: T. Eliasson et al., MYOCARDIAL TURNOVER OF ENDOGENOUS OPIOIDS AND CALCITONIN-GENE-RELATEDPEPTIDE IN THE HUMAN HEART AND THE EFFECTS OF SPINAL-CORD STIMULATIONON PACING-INDUCED ANGINA-PECTORIS, Cardiology, 89(3), 1998, pp. 170-177
Authors:
DICKSTEIN K
KOPP U
MANHENKE C
AARSLAND T
WAAGSTEIN F
MOBINI R
MCNAY J
Citation: K. Dickstein et al., THE HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF MOXONIDINE, A SYMPATHETICINHIBITOR, IN CONGESTIVE-HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7275-7275
Authors:
WAAGSTEIN F
Citation: F. Waagstein, METOPROLOL IN ADDITION TO ACE-INHIBITORS CAUSES REGRESSION OF LEFT-VENTRICULAR DILATATION AND INCREASES EXERCISE ELECTION FRACTION IN ISCHEMIC CARDIOMYOPATHY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7526-7526
Authors:
SWEDBERG K
WAAGSTEIN F
DICKSTEIN K
WILTSE C
MCNAY J
Citation: K. Swedberg et al., MOXONIDINE, A CENTRALLY ACTING SYMPATHETIC INHIBITOR, CAUSES SUSTAINED REDUCTION OF PLASMA NOREPINEPHRINE IN HEART-FAILURE PATIENTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7625-7625
Authors:
GENTHZOTZ S
DARIUS H
ZOTZ RJ
SIGMUND M
KALLEN C
HANRATH P
HARTMANN D
WAAGSTEIN F
TREESE N
MEYER J
Citation: S. Genthzotz et al., MIC TRIAL - METOPROLOL IN PATIENTS WITH MILD AND MODERATE CONGESTIVE-HEART-FAILURE - EFFECTS ON LEFT-VENTRICULAR FUNCTION AND CARDIOPULMONARY EXERCISE TESTING, Journal of the American College of Cardiology, 29(2), 1997, pp. 10415-10415
Authors:
WAAGSTEIN F
ANDERSSON F
Citation: F. Waagstein et F. Andersson, COST-EFFECTIVENESS OF METOPROLOL IN IDIOPATHIC DILATED CARDIOMYOPATHY, Journal of the American College of Cardiology, 29(2), 1997, pp. 17144-17144
Authors:
ANDERSSON B
WAAGSTEIN F
Citation: B. Andersson et F. Waagstein, 3-YEAR FOLLOW-UP OF THE METOPROLOL IN DILATED CARDIOMYOPATHY TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 99654-99654
Authors:
REMME WJ
CLELAND JGF
DARGIE H
ERDMANN E
FERRARI R
KJEKSHUS J
KOMAJDA M
POOLEWILSON PA
RIEGGER G
SOLERSOLER J
TAVAZZI L
SWEDBERG K
WAAGSTEIN F
Citation: Wj. Remme et al., THE TREATMENT OF HEART-FAILURE, European heart journal, 18(5), 1997, pp. 736-753
Authors:
NORRSELL H
ELIASSON T
MANNHEIMER C
AUGUSTINSSON LE
BERGH CH
ANDERSSON B
WAAGSTEIN F
FRIBERG P
Citation: H. Norrsell et al., EFFECTS OF PACING-INDUCED MYOCARDIAL STRESS AND SPINAL-CORD STIMULATION ON WHOLE-BODY AND CARDIAC NOREPINEPHRINE SPILLOVER, European heart journal, 18(12), 1997, pp. 1890-1896
Authors:
HJALMARSON A
KNEIDER M
WAAGSTEIN F
Citation: A. Hjalmarson et al., THE ROLE OF BETA-BLOCKERS IN LEFT-VENTRICULAR DYSFUNCTION AND HEART-FAILURE, Drugs, 54(4), 1997, pp. 501-510
Authors:
HERLITZ J
WAAGSTEIN F
LINDQVIST J
SWEDBERG K
HJALMARSON A
Citation: J. Herlitz et al., EFFECT OF METOPROLOL ON THE PROGNOSIS FOR PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION AND INDIRECT SIGNS OF CONGESTIVE-HEART-FAILURE (A SUBGROUP ANALYSIS OF THE GOTEBORG METOPROLOL TRIAL), The American journal of cardiology, 80(9B), 1997, pp. 40-44
Authors:
WAAGSTEIN F
Citation: F. Waagstein, EFFICACY OF BETA-BLOCKERS IN IDIOPATHIC DILATED CARDIOMYOPATHY AND ISCHEMIC CARDIOMYOPATHY, The American journal of cardiology, 80(9B), 1997, pp. 45-49
Authors:
HJALMARSON A
GOLDSTEIN S
FAGERBERG B
WEDEL H
KJEKSHUS J
WAAGSTEIN F
ELALLAF D
VITOVEC J
ALDERSHVILE J
HALINEN M
DIETZ R
NEUHAUS KL
JANOSI A
THORGEIRSSON G
DUNSELMAN PHJM
GULLESTAD L
KUCH J
HERLITZ J
RICKENBACHER P
BALL SG
GOTTLIEB S
DEEDWANIA P
CHATTERJEE K
DEMETS D
JULIAN D
LEHTO S
MOTZ W
SAMUELSSON O
ANDERSSON B
Citation: A. Hjalmarson et al., RATIONALE, DESIGN, AND ORGANIZATION OF THE METOPROLOL CR XL RANDOMIZED INTERVENTION TRIAL IN HEART-FAILURE (MERIT-HF)/, The American journal of cardiology, 80(9B), 1997, pp. 54-58
Authors:
WAAGSTEIN F
Citation: F. Waagstein, RELIEF FOR CARDIAC-INSUFFICIENCY - BETA-B LOCKERS IN IDIOPATHIC AND ISCHEMIC CARDIOMYOPATHY, Perfusion, 9(8), 1996, pp. 321-321
Authors:
WIKLUND I
WAAGSTEIN F
SWEDBERG K
HJALMARSSON A
Citation: I. Wiklund et al., QUALITY-OF-LIFE ON TREATMENT WITH METOPROLOL IN DILATED CARDIOMYOPATHY - RESULTS FROM THE MDC-TRIAL, Cardiovascular drugs and therapy, 10(3), 1996, pp. 361-368
Authors:
CLELAND JGF
BRISTOW MR
ERDMANN E
REMME WJ
SWEDBERG K
WAAGSTEIN F
Citation: Jgf. Cleland et al., BETA-BLOCKING-AGENTS IN HEART-FAILURE - SHOULD THEY BE USED AND HOW, European heart journal, 17(11), 1996, pp. 1629-1639
Authors:
SYLVEN C
JANSSON E
SOTONYI P
WAAGSTEIN F
BARKHEM T
BRONNEGARD M
Citation: C. Sylven et al., CARDIAC NUCLEAR HORMONE-RECEPTOR MESSENGER-RNA IN HEART-FAILURE IN MAN, Life sciences, 59(22), 1996, pp. 1917-1922
Authors:
ELAM M
JANSSON PA
WAAGSTEIN F
ERIKSSON JW
Citation: M. Elam et al., SYMPATHOADRENAL AND CARDIOVASCULAR FUNCTION IN FIRST-DEGREE RELATIVESOF NIDDM PATIENTS, Diabetologia, 39, 1996, pp. 290-290
Authors:
HJALMARSON AC
WAAGSTEIN F
SWEDBERG K
Citation: Ac. Hjalmarson et al., A MARKED IMPROVEMENT OF CARDIAC-FUNCTION IN 2 THIRDS OF PATIENTS WITHIDIOPATHIC DILATED CARDIOMYOPATHY WITH LONG-TERM METOPROLOL IN THE MDC TRIAL, Circulation, 94(8), 1996, pp. 2536-2536
Authors:
WESTHEIM A
BOSTROM PA
TOIVONEN L
PARIKKA H
CHRISTENSEN C
WAAGSTEIN F
Citation: A. Westheim et al., HEMODYNAMIC-EFFECTS OF AN ENDOPEPTIDASE INHIBITOR CANDOXATRIL COMPARED WITH FRUSEMIDE IN MILD CHRONIC HEART-FAILURE, Circulation, 94(8), 1996, pp. 3649-3649
Authors:
HERLITZ J
HJALMARSON A
WAAGSTEIN F
Citation: J. Herlitz et al., EFFECT OF METOPROLOL AMONG PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION AND SIGNS OF CONGESTIVE-HEART-FAILURE, Circulation, 94(8), 1996, pp. 3882-3882
Authors:
ANDERSSON B
CAIDAHL K
DILENARDA A
WARREN SE
GOSS F
WALDENSTROM A
PERSSON S
WALLENTIN I
HJALMARSON A
WAAGSTEIN F
Citation: B. Andersson et al., CHANGES IN EARLY AND LATE DIASTOLIC FILLING PATTERNS INDUCED BY LONG-TERM ADRENERGIC BETA-BLOCKADE IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY, Circulation, 94(4), 1996, pp. 673-682
Authors:
LINDELOW B
ANDERSSON B
WAAGSTEIN F
BERGH CH
Citation: B. Lindelow et al., PROGNOSIS OF ALTERNATIVE THERAPIES IN PATIENTS WITH HEART-FAILURE NOTACCEPTED FOR HEART-TRANSPLANTATION, The Journal of heart and lung transplantation, 14(6), 1995, pp. 1204-1211
Authors:
SYLVEN C
JANSSON E
SOTONYI P
WAAGSTEIN F
BRONNEGARD M
Citation: C. Sylven et al., NA,K-ATPASE RECEPTOR SUBUNITS ALPHA-1, ALPHA-2 AND ALPHA-3 MESSENGER-RNA IN DILATED CARDIOMYOPATHY, Biological & pharmaceutical bulletin, 18(6), 1995, pp. 907-909